DrugDashboards

Daptomycin in Sodium Chloride

Daptomycin in Sodium Chloride · DAPTOMYCIN 500 mg/50mL · Injection, Solution · Intravenous · Baxter Healthcare Corporation

NDC 00338-0714-24 · 24 BAG in 1 CARTON / 50 mL in 1 BAG · NDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. One of its named manufacturing plants, Baxter Healthcare Corporation, failed FDA inspectionwithin the last two years — the agency’s most serious outcome.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$39.00
Reported to Texas DSHS · 2026 annual filing · Baxter Healthcare Corporation

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 1 MG
$0.060
HCPCS J0874 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$58,402
630 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA213645
TE code
Approval date
Jan 25, 2022
Patents / exclusivity
1 patents, 0 exclusivities
TypeNumber / codeExpires
patent11173189Mar 11, 2041

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Daptomycin in Sodium Chloride (Injection, Solution)

LabelerStrengthFirst seenLast seen
Baxter Healthcare CorporationDAPTOMYCIN 1000 mg/100mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationDAPTOMYCIN 350 mg/50mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationDAPTOMYCIN 500 mg/50mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationDAPTOMYCIN 700 mg/100mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Daptomycin in Sodium Chloride — NDC 00338-0714-24," retrieved September 3, 2026, https://drugdashboards.com/drug/00338071424.

Free to cite with attribution — see how the data is put together.